Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine Plus Bevacizumab in Elderly NSCLC
NCT00309998Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Sep 2005
- Primary completion
- May 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in non-small cell lung cancer (NSCLC), sponsored by University of Rochester. Started Sep 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00309998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309998.